Preglomerular responses to vasoactive agonists utilize calcium release
d from intracellular stores and activation of calcium influx pathways
to elicit vasoconstriction. The current study was performed to determi
ne the role of calcium release from intracellular stores on the affere
nt arteriolar response to increases in perfusion pressure. Experiments
were performed, in vitro, using the blood perfused, juxtamedullary ne
phron technique combined with videomicroscopy. The response of afferen
t arterioles to 30 mm Hg increases in perfusion pressure was determine
d before and after depletion of intracellular calcium pools with a 10-
minute preincubation with 1 mu mol/L thapsigargin or 100 mu mol/L cycl
opiazonic acid. Afferent arteriolar diameter averaged 20.2+/-1.0 mu m
(n=19) at a control perfusion pressure of 100 mm Hg, Increasing perfus
ion pressure to 130 and 160 mm Hg reduced afferent caliber by 10.7+/-1
.0% (P<.05 versus con) and by 24.7+/-1.6% (P<.05 versus diameter at 13
0 mm Hg); respectively. Thapsigargin significantly increased afferent
diameter by 21+/-2% (n=6) at 100 mm Hg and prevented pressure-induced
autoregulatory responses, Afferent diameter averaged 24.3+/-1.7, 24.5/-1.8 and 24.3+/-1.8 mu m at perfusion pressures of 100, 130 and 160 m
m Hg; respectively. Cyclopiazonic acid treatment also inhibited autore
gulatory behavior but did not alter resting vessel diameter. Afferent
arteriolar diameter (n=6) averaged 21.4+/-1.9 mu m at 100 mm Hg and 20
.9+/-2.1 and 20.5+/-2.2 mu m at 130 and 160 mm Hg; respectively. Addit
ional studies were performed to assess the role of phospholipase C act
ivity in pressure-mediated autoregulatory behavior of afferent arterio
les. Step increases in perfusion pressure decreased afferent diameter
by 10.7+/-3.8 and 21.7+/-4.1%; respectively, Administration of the pho
spholipase C inhibitor, U-73122, (5 mu moles/L) did not significantly
alter baseline diameter but did attenuate the pressure-mediated vasoco
nstrictor response. Increasing perfusion pressure to 130 and 160 mm Hg
reduced afferent diameter by only 6.5+/-1.5 and 10.0+/-2.0%; respecti
vely, These data demonstrate that interruption of calcium mobilization
with thapsigargin, cyclopiazonic acid, or phospholipase C inhibition
markedly attenuates pressure-mediated afferent arteriolar vasoconstric
tion and suggests that autoregulatory adjustments in afferent arteriol
ar diameter involve calcium release from inositoltrisphosphate(IP3)-se
nsitive intracellular stores.